Agios Pharmaceuticals' focus is on expanding Pyrukund's label to treat thalassemia and sickle cell disease, targeting multi-billion dollar markets. Despite promising Phase 3 results, safety ...
Scotiabank lowered the firm’s price target on Agios Pharmaceuticals (AGIO) to $74 from $75 and keeps an Outperform rating on the shares. The firm is impressed by the company’s regulatory and ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Realty Income (NYSE: O) and Agree Realty (NYSE: ADC) are two of the best monthly dividend stocks. We recently compiled a list of the 12 Best Stocks That Pay Monthly Dividends in 2025. In this ...
When it comes to avoiding Greece's most popular, crowded destinations but still experiencing the history and beauty, head to ...
After hours: 7:58:01 pm GMT-5 ...